Factors associated with nonresponse to ovulation induction using letrozole among women with World Health Organization group II anovulation
Context: Letrozole, a third generation aromatase inhibitor is gaining importance in ovulation induction. Some prefer to use it as a second line agent in women who fail to respond to clomifene citrate. However, our knowledge about the predictors of response to letrozole is limited. Aims: The study wa...
Saved in:
Main Authors: | Thilina Sanjeewa Palihawadana (Author), Prasantha Sudehana Wijesinghe (Author), Harshalal Rukka Seneviratne (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current evidence supporting "letrozole" for ovulation induction
by: Sujata Kar
Published: (2013) -
Induction of ovulation with letrozole in women with polycystic ovary syndrome
by: G E Chernukha, et al.
Published: (2017) -
Letrozole 2.5 mg Shows Higher Endometrial Thickness Compared to 5 mg Letrozole in Ovulation Induction
by: Anita Tobing
Published: (2012) -
Comparison of ovulation induction with letrozole plus dexamethasone and letrozole alone in infertile women with polycystic ovarian disease: An RCT
by: Farahnaz Farzaneh, et al.
Published: (2020) -
A comparison of letrozole regimens for ovulation induction in women with polycystic ovary syndrome
by: Rachel S. Mandelbaum, M.D, et al.
Published: (2024)